Literature DB >> 4715260

The susceptibility of rat strains to experimental allergic encephalomyelitis.

R A Hughes, J Stedronska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4715260      PMCID： PMC1422816     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  8 in total

1.  Technique of complementfixation test applicable to the diagnosis of virus diseases.

Authors:  C M BRADSTREET; C E TAYLOR
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1962-05

2.  Studies on the mechanism of altered susceptibility to experimental allergic encephalomyelitis.

Authors:  S LEVINE; E J WENK
Journal:  Am J Pathol       Date:  1961-10       Impact factor: 4.307

3.  Role of heredity in experimental disseminated encephalomyelitis in mice.

Authors:  J M LEE; P K OLITSKY; H A SCHNEIDER; N D ZINDER
Journal:  Proc Soc Exp Biol Med       Date:  1954-03

4.  An electron microscopical comparison of primary and secondary demyelination in the rat central nervous system.

Authors:  J I Howell; M Kidd
Journal:  Virchows Arch B Cell Pathol       Date:  1969

5.  Induction of experimental allergic encephalomyelitis in Lewis rats.

Authors:  P Y Paterson; D G Drobish; M A Hanson; A F Jacobs
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

Review 6.  Immunological facilitation, a broadening of the concept of the enhancement phenomenon.

Authors:  G A Voisin
Journal:  Prog Allergy       Date:  1971

7.  Immunochemical studies of organ and tumour lipids. XVII. The existence of two complement-fixing systems involving cerebroside.

Authors:  M M Rapport; R Cavanna; L Graf
Journal:  J Neurochem       Date:  1967-01       Impact factor: 5.372

8.  Suppression of allergic encephalomyelitis in rats by means of antibrain serum.

Authors:  P Y PATERSON; S M HARWIN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307
  8 in total
  14 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Successful treatment of IgM paraproteinaemic neuropathy with fludarabine.

Authors:  H C Wilson; M P Lunn; S Schey; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

3.  Hyper-responsiveness in NZB mice to the experimental induction of anti-red cell autoantibody.

Authors:  A Cooke; J H Playfair
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

4.  In situ Ia expression on brain cells in the rat: autoimmune encephalomyelitis-resistant strain (BN) and susceptible strain (Lewis) compared.

Authors:  Y Matsumoto; K Kawai; M Fujiwara
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

5.  Reactivity of neuro-antigen-sensitized lymphocytes against syngeneic, allogeneic and tolerated allogeneic neural tissue.

Authors:  J Cunningham; P McCullagh
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

6.  Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.

Authors:  Y Matsumoto; K Kawai; Y Tomita; M Fujiwara
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

7.  Biological effects of cyclosporin A: a new antilymphocytic agent. 1976.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1994-12

8.  The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat.

Authors:  D Mason; I MacPhee; F Antoni
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

9.  Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis.

Authors:  R A Hughes; S Leibowitz
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

10.  Immune responses in experimental allergic neuritis.

Authors:  R A Hughes; M Kadlubowski; I A Gray; S Leibowitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-07       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.